| Name | Title | Contact Details |
|---|---|---|
Pierre Gravier |
Chief Financial Officer | Profile |
Steve DeMarco |
Director Pre-clinical R&D, Gene Therapy | Profile |
Laurie Sokol |
Senior Director R&D Finance | Profile |
Ida Licata |
Executive Director FP&A - R&D | Profile |
Tom Hernandez |
Sr. Director - R&D FP&A | Profile |
Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease.
Centerfirst was founded in early 2004 to help healthcare leaders maximize the value of their call centers.
Girindus America is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Dyne was founded with a singular focus: to transform the lives of people with serious muscle diseases by pioneering muscle-targeted therapies. Our proprietary technologies provide the foundation for breakthrough treatments. We have assembled a world-class team of experts who are united by their commitment to fulfill this mission.